Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
Journal of Gastroenterology|June 1, 2017
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in JapanGoki Suda, Norihiro Furusyo, Hidenori Toyoda, et al.
Journal of Lipid Research|November 8, 2019
The interaction between ABCA1 polymorphism and physical activity on the HDL-cholesterol levels in a Japanese populationYuichiro Nishida, Tsuyoshi Hachiya, Megumi Hara, et al.
Journal of Atherosclerosis and Thrombosis|September 15, 2017
Genetic Variants of RAMP2 and CLR are Associated with StrokeTeruhide Koyama, Nagato Kuriyama, Etsuko Ozaki, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2023
Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational studyEiichi Ogawa, Dae Won Jun, Hidenori Toyoda, et al.
The Lancet. Gastroenterology & Hepatology|March 24, 2019
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysisJie Li, Biyao Zou, Yee Hui Yeo, et al.
Scientific Reports|January 26, 2018
A genome-wide association study in the Japanese population identifies the 12q24 locus for habitual coffee consumption: The J-MICC StudyHiroko Nakagawa-Senda, Tsuyoshi Hachiya, Atsushi Shimizu, et al.
Journal of Hepatology|May 15, 2018
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infectionKosh Agarwal, Maurizia Brunetto, Wai Kay Seto, et al.
Medicine and Science in Sports and Exercise|August 14, 2018
Genomewide Association Study of Leisure-Time Exercise Behavior in Japanese AdultsMegumi Hara, Tsuyoshi Hachiya, Yoichi Sutoh, et al.
Hepatology International|December 5, 2020
HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohortYasuhito Tanaka, Eiichi Ogawa, Chung-Feng Huang, et al.
Pageof 20